Literature DB >> 3539001

Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases.

P Brown, F Cathala, P Castaigne, D C Gajdusek.   

Abstract

In this consecutive series of 230 patients with neuropathologically verified Creutzfeldt-Jakob disease (CJD), the disease was found to affect men and women with approximately equal frequency in a peak plateau between the ages of 55 and 75 years (mean, 61.5 years). Familial cases accounted for 4 to 8% of the total series. Nonspecific prodromal symptoms occurred in one third of the patients, and the neurological presentation, although usually a gradually evolving mental deterioration, was of rapid onset in 20% of patients and in 36% of patients consisted exclusively of neurological symptoms. The great majority of these symptoms were of cerebellar or visual origin. Extrapyramidal muscular rigidity, myoclonus, and characteristic periodic electroencephalographic (EEG) complexes were observed comparatively late in the illness, and some type of involuntary movement or periodic EEG activity was seen in over 95% of the patients. The median duration of illness was 4 months (mean, 7.6 months); 90% of patients died within a year of onset.

Entities:  

Mesh:

Year:  1986        PMID: 3539001     DOI: 10.1002/ana.410200507

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  69 in total

1.  Progressive aphasia with rapidly progressive dementia in a 49 year old woman.

Authors:  J D Greene; J R Hodges; J W Ironside; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

Review 2.  Emerging patterns of diffusion-weighted MR imaging in Creutzfeldt-Jakob disease: case report and review of the literature.

Authors:  Yang Mao-Draayer; Steven P Braff; Keith J Nagle; William Pendlebury; Paul L Penar; Robert E Shapiro
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

Review 3.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

Review 4.  Drug-induced Creutzfeldt-Jakob like syndrome.

Authors:  P F Finelli
Journal:  J Psychiatry Neurosci       Date:  1992-09       Impact factor: 6.186

5.  Magnetic resonance imaging follow-up in Creutzfeldt-Jakob disease.

Authors:  J Röther; A Schwartz; M Härle; K U Wentz; P Berlit; M Hennerici
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

6.  Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.

Authors:  Piero Parchi; Maura Cescatti; Silvio Notari; Walter J Schulz-Schaeffer; Sabina Capellari; Armin Giese; Wen-Quan Zou; Hans Kretzschmar; Bernardino Ghetti; Paul Brown
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

Review 7.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Huidy Shu; Aissa Haman; James J Sejvar; Bruce L Miller
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

8.  Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

Authors:  Michael D Geschwind; K Meng Tan; Vanda A Lennon; Ramon F Barajas; Aissa Haman; Christopher J Klein; S Andrew Josephson; Sean J Pittock
Journal:  Arch Neurol       Date:  2008-10

9.  18F-fluorodeoxyglucose-PET and 99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease.

Authors:  F Grünwald; C Pohl; H Bender; A Hartmann; C Menzel; J Ruhlmann; E Keller; H J Biersack
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

10.  Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD).

Authors:  R Gabizon; H Rosenmann; Z Meiner; I Kahana; E Kahana; Y Shugart; J Ott; S B Prusiner
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.